Severe infections requiring intensive care unit admission in patients receiving ibrutinib for hematological malignancies: a groupe de recherche respiratoire en réanimation onco-hématologique (GRRR-OH) study

Severe infections requiring intensive care unit admission in patients receiving ibrutinib for hematological malignancies: a groupe de recherche respiratoire en réanimation onco-hématologique (GRRR-OH) study

Abstract Background In the last decade, Ibrutinib has become the standard of care in the treatment of several lymphoproliferative diseases such as chronic lymphocytic leukemia (CLL) and several non-Hodgkin lymphoma. Beyond Bruton tyrosine kinase inhibition, Ibrutinib shows broad immunomodulatory eff...

Full description

Bibliographic Details
Main Authors: Louise Baucher, Virginie Lemiale, Adrien Joseph, Florent Wallet, Marc Pineton de Chambrun, Alexis Ferré, Romain Lombardi, Laura Platon, Adrien Contejean, Charline Fuseau, Laure Calvet, Frédéric Pène, Achille Kouatchet, Djamel Mokart, Elie Azoulay, Antoine Lafarge
Format: Article
Language:English
Published: SpringerOpen 2023-12-01
Series:Annals of Intensive Care
Subjects:
Ibrutinib
Opportunistic infections
Intensive care
Lymphoproliferative disease
Targeted drugs
Online Access:https://doi.org/10.1186/s13613-023-01219-5

Internet

https://doi.org/10.1186/s13613-023-01219-5

Similar Items